303
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Effect of cardiovascular drugs on mortality in atrial fibrillation and chronic heart failure

, , , , &
Pages 291-298 | Received 31 Mar 2014, Accepted 30 Jun 2014, Published online: 06 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Juraj Sokol, Frantisek Nehaj, Jela Ivankova, Michal Mokan, Marian Mokan & Jan Stasko. (2018) Dabigatran affects thrombin-dependent platelet aggregation after a week-long therapy. Scandinavian Cardiovascular Journal 52:4, pages 227-231.
Read now
Dag Steinar Thelle. (2014) Validity and selection. Scandinavian Cardiovascular Journal 48:5, pages 259-261.
Read now

Articles from other publishers (2)

Per Wändell, Axel C. Carlsson, Martin J. Holzmann, Johan Ärnlöv, Jan Sundquist & Kristina Sundquist. (2018) Associations between relevant cardiovascular pharmacotherapies and incident heart failure in patients with atrial fibrillation. Journal of Hypertension 36:9, pages 1929-1935.
Crossref
Per Wändell, Axel C. Carlsson, Danijela Gasevic, Jan Sundquist & Kristina Sundquist. (2016) Neighbourhood socio-economic status and all-cause mortality in adults with atrial fibrillation: A cohort study of patients treated in primary care in Sweden. International Journal of Cardiology 202, pages 776-781.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.